参考文献/References:
[1] Wu J,He S,Song Z,et al. Macrophage polarization states in atherosclerosis[J]. Front Immunol,2023,14:1185587.
[2] Gusev E,Sarapultsev A. Atherosclerosis and inflammation: Insights from the theory of general pathological processes[J]. Int J Mol Sci,2023,24(9):7910.
[3] Xu S,Ilyas I,Little PJ,et al. Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies[J]. Pharmacol Rev,2021,73(3):924-967.
[4] Jinnouchi H,Guo L,Sakamoto A,et al. Diversity of macrophage phenotypes and responses in atherosclerosis[J]. Cell Mol Life Sci,2020,77(10):1919-1932.
[5] Hou P,Fang J,Liu Z,et al. Macrophage polarization and metabolism in atherosclerosis[J]. Cell Death Dis,2023,14(10):691.
[6] Ma J,Zhang H,Chen Y,et al. The role of macrophage iron overload and ferroptosis in atherosclerosis[J]. Biomolecules,2022,12(11):1702.
[7] Chen R,Zhang H,Tang B,et al. Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets[J]. Signal Transduct Target Ther,2024,9(1):130.
[8] Wei X,Xie F,Zhou X,et al. Role of pyroptosis in inflammation and cancer[J]. Cell Mol Immunol,2022,19(9):971-992.
[9] Newton K,Strasser A,Kayagaki N,et al. Cell death[J]. Cell,2024,187(2):235-256.
[10] Rao Z,Zhu Y,Yang P,et al. Pyroptosis in inflammatory diseases and cancer[J]. Theranostics,2022,12(9):4310-4329.
[11] Lin L,Zhang MX,Zhang L,et al. Autophagy,pyroptosis,and ferroptosis: new regulatory mechanisms for atherosclerosis[J]. Front Cell Dev Biol,2021,9:809955.
[12] Qian Z,Zhao Y,Wan C,et al. Pyroptosis in the initiation and progression of atherosclerosis [J]. Front Pharmacol,2021,12:652963.
[13] Wei Y,Yang L,Pandeya A,et al. Pyroptosis-induced inflammation and tissue damage[J]. J Mol Biol,2022,434(4):167301.
[14] Fu J,Wu H. Structural mechanisms of NLRP3 inflammasome assembly and activation[J]. Annu Rev Immunol,2023,41:301-316.
[15] Albosta MS,Grant JK,Taub P,et al. Inclisiran: a new strategy for LDL-C lowering and prevention of atherosclerotic cardiovascular disease[J]. Vasc Health Risk Manag,2023,19:421-431.
[16] Paganelli F,Mottola G,Fromonot J,et al. Hyperhomocysteinemia and cardiovascular disease: is the adenosinergic system the missing link[J]. Int J Mol Sci,2021,22(4):1690.
[17] Luo X,Weng X,Bao X,et al. A novel anti-atherosclerotic mechanism of quercetin: competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis[J]. Redox Biol,2022,57:102511.
[18] Cong L,Liu X,Bai Y,et al. Melatonin alleviates pyroptosis by regulating the SIRT3/FOXO3α/ROS axis and interacting with apoptosis in Atherosclerosis progression[J]. Biol Res,2023,56(1):62.
[19] Zhang S,Lv Y,Luo X,et al. Homocysteine promotes atherosclerosis through macrophage pyroptosis via endoplasmic reticulum stress and calcium disorder[J]. Mol Med,2023,29(1):73.
[20] Baatarjav C,Komada T,Karasawa T,et al. dsDNA-induced AIM2 pyroptosis halts aberrant inflammation during rhabdomyolysis-induced acute kidney injury[J]. Cell Death Differ,2022,29(12):2487-2502.
[21] Fidler TP,Xue C,Yalcinkaya M,et al. The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis[J]. Nature,2021,592(7853):296-301.
[22] Mambwe B,Neo K,Javanmard Khameneh H,et al. Tyrosine dephosphorylation of ASC modulates the activation of the NLRP3 and AIM2 Inflammasomes[J]. Front Immunol,2019,10:1556.
[23] Abu khweek A,Amer AO. Pyroptotic and non-pyroptotic effector functions of caspase-11[J]. Immunol Rev,2020,297(1):39-52.
[24] Jiang M,Sun X,Liu S,et al. Caspase-11-Gasdermin D-mediated pyroptosis is involved in the pathogenesis of atherosclerosis[J]. Front Pharmacol,2021,12:657486.
[25] Zhao F,Guo Z,Hou F,et al. Magnoflorine alleviates "M1" polarized macrophage-induced intervertebral disc degeneration through repressing the HMGB1/Myd88/NF-κB pathway and NLRP3 inflammasome[J]. Front Pharmacol,2021,12:701087.
[26] Liang W,Wei R,Zhu X,et al. Downregulation of HMGB1 carried by macrophage-derived extracellular vesicles delays atherosclerotic plaque formation through Caspase-11-dependent macrophage pyroptosis[J]. Mol Med,2024,30(1):38.
[27] Zhan J,Wang J,Liang Y,et al. Apoptosis dysfunction: unravelling the interplay between ZBP1 activation and viral invasion in innate immune responses[J]. Cell Commun Signal,2024,22(1):149.
[28] Li M,Wang ZW,Fang LJ,et al. Programmed cell death in atherosclerosis and vascular calcification[J]. Cell Death Dis,2022,13(5):467.
[29] Gautier EL,Huby T,Witztum JL,et al. Macrophage apoptosis exerts divergent effects on atherogenesis as a function of lesion stage[J]. Circulation,2009,119(13):1795-804.
[30] Hu Y,Liu Y,Zong L,et al. The multifaceted roles of GSDME-mediated pyroptosis in cancer: therapeutic strategies and persisting obstacles[J]. Cell Death Dis,2023,14(12):836.
[31] Hu Y,Liu Y,Zong L,et al. GSDME-mediated pyroptosis promotes the progression and associated inflammation of atherosclerosis[J]. Cell Death Dis,2023,14(12):836.
[32] Zha S,Yu X,Wang X,et al. Topical simvastatin improves lesions of diffuse normolipemic plane xanthoma by inhibiting foam cell pyroptosis[J]. Front Immunol,2022,13:865704.
[33] Li H,Yang H,Qin Z,et al. Colchicine ameliorates myocardial injury induced by coronary microembolization through suppressing pyroptosis via the AMPK/SIRT1/NLRP3 signaling pathway[J]. BMC Cardiovasc Disord,2024,24(1):23.
[34] Nidorf SM,Fiolet ATL,Mosterd A,et al. Colchicine in patients with chronic coronary disease[J]. N Engl J Med,2020,383(19):1838-1847.
[35] Li Z,Zou X,Lu R,et al. Arsenic trioxide alleviates atherosclerosis by inhibiting CD36-induced endocytosis and TLR4/NF-κB-induced inflammation in macrophage and ApoE-/- mice[J]. Int Immunopharmacol,2024,128:111452.
[36] Burdette BE,Esparza AN,Zhu H,et al. Gasdermin D in pyroptosis[J]. Acta Pharm Sin B,2021,11(9):2768-2782.
[37] Humphries F,Shmuel-galia L,Ketelut-carneiro N,et al. Succination inactivates gasdermin D and blocks pyroptosis[J]. Science,2020,369(6511):1633-1637.
[38] Hu JJ,Liu X,Xia S,et al. Fda-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation[J]. Nat Immunol,2020,21(7):736-745.
相似文献/References:
[1]张伟 黄从新.巨噬细胞与心血管稳态和疾病[J].心血管病学进展,2019,(9):1241.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.014]
ZHANG Wei,HUANG Congxin.Macrophages are Associated with Cardiovascular Homeostasis and Diseases[J].Advances in Cardiovascular Diseases,2019,(12):1241.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.014]
[2]李一凡 张智伟.巨噬细胞相关的外泌体在心血管疾病中的作用研究进展[J].心血管病学进展,2020,(8):839.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.014]
LI Yifan,ZHANG Zhiwei.Role of Macrophage-Related Exosomes in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2020,(12):839.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.014]
[3]陈远洋 王志维.供体巨噬细胞在心脏移植中的研究进展[J].心血管病学进展,2022,(6):514.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.009]
CHEN Yuanyang,WANG Zhiwei.Donor Macrophages in Heart Transplantation[J].Advances in Cardiovascular Diseases,2022,(12):514.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.009]
[4]付韫韬 赵庆彦?/html>.巨噬细胞调控离子通道致心律失常研究的最新进展[J].心血管病学进展,2022,(2):100.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.002]
FU Yuntao ZHAO Qingyan.Macrophages Regulating Ion Channels to Induce Arrhythmia[J].Advances in Cardiovascular Diseases,2022,(12):100.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.002]
[5]陈乾 秦铭 徐志云.单核/巨噬细胞与主动脉瓣钙化研究进展[J].心血管病学进展,2022,(10):898.[doi:10.16806/j.cnki.issn.1004-3934.2022.10.008]
CHEN Qian,QIN Ming,XU Zhiyun.Aortic Valve Calcification Caused by Mononuclear Phagocyte System[J].Advances in Cardiovascular Diseases,2022,(12):898.[doi:10.16806/j.cnki.issn.1004-3934.2022.10.008]
[6]王朝阳 赵丽娜 田师鹏 陈淑霞 谷剑.炎症治疗在动脉粥样硬化中的研究进展[J].心血管病学进展,2023,(6):519.[doi:10.16806/j.cnki.issn.1004-3934.2023.06.009]
WANG Zhaoyang,ZHAO Lina,TIAN Shipeng,et al.Advances in the Treatment of Inflammation in Atherosclerosis[J].Advances in Cardiovascular Diseases,2023,(12):519.[doi:10.16806/j.cnki.issn.1004-3934.2023.06.009]
[7]刘文秀 郭雨桐 孙雪 宋琳琳 刘越 丁雪.Calhex231通过焦亡改善大鼠心肌梗死面积大小及心脏纤维化[J].心血管病学进展,2024,(4):379.[doi:10.16806/j.cnki.issn.1004-3934.2024.04.000]
LIU Wenxiu,GUO Yutong,SUN Xue,et al.Calhex231 Attenuates Rat Myocardial Infarct Size and Fibrosis by Suppressing Pyroptosis[J].Advances in Cardiovascular Diseases,2024,(12):379.[doi:10.16806/j.cnki.issn.1004-3934.2024.04.000]
[8]黄爱宝??少衡.巨噬细胞治疗缺血心肌的研究进展[J].心血管病学进展,2024,(6):543.[doi:10.16806/j.cnki.issn.1004-3934.2024.06.015]
HUANG Aibao,ZHANG Shaoheng?/html>.Research progress in Macrophage Therapy for?schemic Myocardium[J].Advances in Cardiovascular Diseases,2024,(12):543.[doi:10.16806/j.cnki.issn.1004-3934.2024.06.015]